Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Pediatr Crit Care Med. 2016 Dec;17(12):1109–1116. doi: 10.1097/PCC.0000000000000920

Figure 2.

Figure 2

A, The percentage of adverse events (AEs) and severe adverse events (SAEs) by coadministration of adjunctive medications. B, The percentage of AEs and SAEs for weight-adjusted total IV ketamine dose of greater than 5 mg/kg versus less than or equal to 5 mg/kg, regardless of coadministered medications. Data (in B) are from the 2007–2011 subcohort of patients for which dosing data are available.